Skip to main content
SpringerLink
Log in

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours

  • FOCUS ON...
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 1985;62(6):816–22.

    Article  CAS  PubMed  Google Scholar 

  2. Warburg O. The metabolism of tumors. London: Constable; 1930.

    Google Scholar 

  3. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.

    Article  Google Scholar 

  4. Kinahan PE, Doot RK, Wanner-Roybal M, Bidaut LM, Armato SG, Meyer CR, et al. PET/CT assessment of response to therapy: tumor change measurement, truth data and error. Transl Oncol. 2009;2(4):223–30.

    PubMed  Google Scholar 

  5. Nair VS, Krupitskaya Y, Gould MK. Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009;4(12):1473–9.

    Article  PubMed  Google Scholar 

  6. Nair VS, Barnett PG, Ananth L, Gould MK, for the VA SNAP Cooperative Studies Group. Positron emission tomography (PET) 18F-fluorodeoxyglucose (FDG) uptake and prognosis in patients with resected, clinical stage Ia non-small cell lung cancer. Chest. 2009. doi:10.1378/chest.09-2356. Dec 28. [Epub ahead of print].

    Google Scholar 

  7. Dooms C, van Baardwijk A, Verbeken E, van Suylen RJ, Stroobants S, De Ruysscher D, et al. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer. J Thorac Oncol. 2009;4(7):822–8.

    Article  PubMed  Google Scholar 

  8. Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM. Standard uptake value predicts survival in non-small cell lung cancer. Ann Thorac Surg. 2009;88(3):911–5. discussion 915–6.

    Article  PubMed  Google Scholar 

  9. Hofele C, Freier K, Thiele OC, Haberkorn U, Buchmann I. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45(11):963–7.

    Article  PubMed  Google Scholar 

  10. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009;74(4):1054–61.

    PubMed  Google Scholar 

  11. Pan L, Gu P, Huang G, Xue H, Wu S. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2009;21(9):1008–15.

    Article  PubMed  Google Scholar 

  12. Kato H, Nakajima M, Sohda M, Tanaka N, Inose T, Miyazaki T, et al. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer. 2009;115(14):3196–203.

    Article  PubMed  Google Scholar 

  13. Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009;19(5):912–8.

    PubMed  Google Scholar 

  14. Karam M, Ata A, Irish K, Feustel PJ, Mottaghy FM, Stroobants SG, et al. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. Nucl Med Commun. 2009;30(10):770–8.

    Article  PubMed  Google Scholar 

  15. Furukawa H, Ikuma H, Asakura K, Uesaka K. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. J Surg Oncol. 2009;100(6):494–9.

    Article  PubMed  Google Scholar 

  16. Kruer MC, Kaplan AM, Etzl Jr MM, Carpentieri DF, Dickman PS, Chen K, et al. The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood. J Neurooncol. 2009;95(2):239–45.

    Article  PubMed  Google Scholar 

  17. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, et al. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol. 2009;115(1):65–8.

    Article  PubMed  Google Scholar 

  18. Cheon GJ, Kim MS, Lee JA, Lee SY, Cho WH, Song WS, et al. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. J Nucl Med. 2009;50(9):1435–40.

    Article  CAS  PubMed  Google Scholar 

  19. Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer. 2009;115(19):4586–94.

    Article  PubMed  Google Scholar 

  20. Xie P, Yue JB, Fu Z, Feng R, Yu JM. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. Ann Oncol. 2009. doi:10.1093/annonc/mdp430. Nov 13. [Epub ahead of print].

    PubMed  Google Scholar 

  21. Bartel TB, Haessler J, Brown TL, Shaughnessy Jr JD, van Rhee F, Anaissie E, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114(10):2068–76.

    Article  CAS  PubMed  Google Scholar 

  22. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, et al. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer. 2009;115(22):5184–92.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors are grateful to Ms Catherine Wrenn for her advice and skilful editorial support.

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences and Technologies and Center of Molecular and Cellular Imaging (IMAGO), University of Milan, Milan, Italy

    Giovanni Lucignani

  2. Department of Diagnostic Services, Unit of Nuclear Medicine, San Paolo Hospital, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

  3. Nuclear Medicine Service, Donna and Benjamin M. Rosen Chair in Radiology, Molecular Pharmacology and Chemistry, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Steven M. Larson

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven M. Larson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

“Focus on...” abridgements aim to highlight papers published within the past year and draw extensively on the texts and summaries of the articles referenced. Less recent citations are also included when deemed useful to provide background information on the topic reviewed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G., Larson, S.M. Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours. Eur J Nucl Med Mol Imaging 37, 1032–1038 (2010). https://doi.org/10.1007/s00259-010-1428-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1428-y

Keywords

Search

Navigation